Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development

Contributed by: Business Wire

Logo

Business Wire logo

Images

Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, President & CEO, Rigaku
Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, President & CEO, Rigaku
Business Wire embedded0

Tags

Research
Pharmaceutical
Technology
Other Manufacturing
Health Technology
Science
Nanotechnology
Chemicals/Plastics
Biotechnology
Other Technology
Manufacturing
Health
SPERA PHARMA

More Like This

XSPA-200 ER mounted on a MiniFlex (Photo: Business Wire)

Rigaku Announces XSPA-200 ER Detector for X-ray Diffraction System

Ribbon Cutting of the Lab (Photo: Business Wire)

Rigaku BioScience Lab Opens in USA

EDT device (Photo: Business Wire)

Rigaku: Novel Electron Density Topography Technology to Reveal Biological Macromolecules’ Properties

Listing on the Tokyo Stock Exchange Prime Market

Avishai Shklar, Chief Executive Officer (CEO) of RSI (Photo: Business Wire)

The Rigaku Group’s XwinSys Changes its Name to Rigaku Semiconductor Instruments

Change in sales structure after the launch of DXPS (Graphic: Business Wire)

Notice of Commencement of Operation of Dexerials Photonics Solutions Corporation as Integrated Company Leading Growth in the Photonics Domain

Rigaku Holdings Corporation: Approval of Listing on the Tokyo Stock Exchange Prime Market

Kyowa Kirin International and NewBridge Pharmaceuticals Enter Into Agreement to Improve Access to Medicines for Rare Disease Patients Across Middle East and North Africa